StockData
HUTCHMED (China) Ltd logo

HUTCHMED (China) Ltd (HCM) stock

HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026Score 5/30
$14.40−0.33 (-2.24%)

Close on Nov 17, 2026Market cap $2.51BP/E 5.5Yield –

HUTCHMED (China) operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

HUTCHMED (China)'s operating cash flow for the twelve months ending Dec 31, 2019 was -$80.91M. For fiscal 2025 it was -$64.66M, down 13109.5% from the year before. The highest annual figure on record is $219.26M in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$64.66M-13109.5%
FY2024Dec 31, 2024$497.00K-99.8%
FY2023Dec 31, 2023$219.26M–
FY2022Dec 31, 2022-$268.60M–
FY2021Dec 31, 2021-$204.22M–
FY2020Dec 31, 2020-$62.07M–
FY2019Dec 31, 2019-$80.91M–
FY2018Dec 31, 2018-$32.85M–
FY2017Dec 31, 2017-$8.94M–
FY2016Dec 31, 2016-$9.57M–
FY2015Dec 31, 2015-$9.39M-212.3%
FY2014Dec 31, 2014$8.36M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019-$17.39M–
Q3 FY2019Sep 30, 2019-$33.48M–
Q2 FY2019Jun 30, 2019-$1.12M-109.2%
Q1 FY2019Mar 31, 2019-$28.92M–
Q4 FY2018Dec 31, 2018-$13.94M–
Q3 FY2018Sep 30, 2018-$315.00K–
Q2 FY2018Jun 30, 2018$12.24M–
Q1 FY2018Mar 31, 2018-$30.84M–

More HUTCHMED (China) figures

See a number that looks wrong?